{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:22:26Z","timestamp":1793823746326,"version":"4.6.1"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81701192, 81901380"],"award-info":[{"award-number":["81701192, 81901380"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81701192, 81901380"],"award-info":[{"award-number":["81701192, 81901380"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81701192, 81901380"],"award-info":[{"award-number":["81701192, 81901380"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81701192, 81901380"],"award-info":[{"award-number":["81701192, 81901380"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81701192, 81901380"],"award-info":[{"award-number":["81701192, 81901380"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81701192, 81901380"],"award-info":[{"award-number":["81701192, 81901380"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"DOI":"10.1007\/s10753-025-02323-3","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T03:13:54Z","timestamp":1751426034000},"page":"4240-4256","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["MLKL Modulates Necroptosis and Neuroinflammation in a Mouse Model of MS"],"prefix":"10.1007","volume":"48","author":[{"given":"Minjun","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueli","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"issue":"6","key":"2323_CR1","doi-asserted-by":"publisher","first-page":"530","DOI":"10.7861\/clinmedicine.17-6-530","volume":"17","author":"A Doshi","year":"2017","unstructured":"Doshi, A., and J. Chataway. 2017. Multiple sclerosis, a treatable disease. Clinical Medicine (London, England) 17 (6): 530\u2013536.","journal-title":"Clinical Medicine (London, England)"},{"key":"2323_CR2","doi-asserted-by":"crossref","unstructured":"Lassmann, H. 2018. Multiple sclerosis pathology. Cold Spring Harbor Perspectives in Medicine 8 (3): a028936.","DOI":"10.1101\/cshperspect.a028936"},{"issue":"1","key":"2323_CR3","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/ene.13819","volume":"26","author":"R Dobson","year":"2019","unstructured":"Dobson, R., and G. Giovannoni. 2019. Multiple sclerosis - a review. European Journal of Neurology 26 (1): 27\u201340.","journal-title":"European Journal of Neurology"},{"issue":"9","key":"2323_CR4","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s11882-023-01102-0","volume":"23","author":"ES Vasileiou","year":"2023","unstructured":"Vasileiou, E.S., and K.C. Fitzgerald. 2023. Multiple sclerosis pathogenesis and updates in targeted therapeutic approaches. Current Allergy and Asthma Reports 23 (9): 481\u2013496.","journal-title":"Current Allergy and Asthma Reports"},{"key":"2323_CR5","doi-asserted-by":"crossref","unstructured":"Walton, C., et al. 2020. Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition. Multiple Sclerosis 26 (14): 1816\u20131821.","DOI":"10.1177\/1352458520970841"},{"issue":"9","key":"2323_CR6","doi-asserted-by":"publisher","first-page":"e00362","DOI":"10.1002\/brb3.362","volume":"5","author":"N Garg","year":"2015","unstructured":"Garg, N., and T.W. Smith. 2015. An update on immunopathogenesis, diagnosis, and treatment of multiple sclerosis. Brain and Behavior: A Cognitive Neuroscience Perspective 5 (9): e00362.","journal-title":"Brain and Behavior: A Cognitive Neuroscience Perspective"},{"issue":"12","key":"2323_CR7","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.amjmed.2020.05.049","volume":"133","author":"SL Hauser","year":"2020","unstructured":"Hauser, S.L., and B. Cree. 2020. Treatment of multiple sclerosis: A review. American Journal of Medicine 133 (12): 1380-1390.e2.","journal-title":"American Journal of Medicine"},{"issue":"1\u20132","key":"2323_CR8","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jneuroim.2010.10.021","volume":"231","author":"R Milo","year":"2011","unstructured":"Milo, R., and H. Panitch. 2011. Combination therapy in multiple sclerosis. Journal of Neuroimmunology 231 (1\u20132): 23\u201331.","journal-title":"Journal of Neuroimmunology"},{"issue":"4","key":"2323_CR9","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.neuron.2018.01.021","volume":"97","author":"C Baecher-Allan","year":"2018","unstructured":"Baecher-Allan, C., B.J. Kaskow, and H.L. Weiner. 2018. Multiple sclerosis: Mechanisms and immunotherapy. Neuron 97 (4): 742\u2013768.","journal-title":"Neuron"},{"issue":"7","key":"2323_CR10","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1093\/brain\/awab059","volume":"144","author":"S Ghorbani","year":"2021","unstructured":"Ghorbani, S., and V.W. Yong. 2021. The extracellular matrix as modifier of neuroinflammation and remyelination in multiple sclerosis. Brain 144 (7): 1958\u20131973.","journal-title":"Brain"},{"key":"2323_CR11","doi-asserted-by":"publisher","first-page":"760","DOI":"10.3389\/fimmu.2020.00760","volume":"11","author":"J van Langelaar","year":"2020","unstructured":"van Langelaar, J., et al. 2020. B and T cells driving multiple sclerosis: Identity, mechanisms and potential triggers. Front Immunol 11: 760.","journal-title":"Front Immunol"},{"issue":"4","key":"2323_CR12","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/S1474-4422(14)70305-9","volume":"14","author":"B Hemmer","year":"2015","unstructured":"Hemmer, B., M. Kerschensteiner, and T. Korn. 2015. Role of the innate and adaptive immune responses in the course of multiple sclerosis. Lancet Neurology 14 (4): 406\u2013419.","journal-title":"Lancet Neurology"},{"issue":"1","key":"2323_CR13","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41572-018-0041-4","volume":"4","author":"M Filippi","year":"2018","unstructured":"Filippi, M., et al. 2018. Multiple sclerosis. Nat Rev Dis Primers 4 (1): 43.","journal-title":"Nat Rev Dis Primers"},{"key":"2323_CR14","doi-asserted-by":"publisher","first-page":"113764","DOI":"10.1016\/j.jim.2024.113764","volume":"534","author":"W Wu","year":"2024","unstructured":"Wu, W., et al. 2024. High-yield production of recombinant human myelin oligodendrocyte glycoprotein in SHuffle bacteria without a refolding step. Journal of Immunological Methods 534: 113764.","journal-title":"Journal of Immunological Methods"},{"issue":"28","key":"2323_CR15","doi-asserted-by":"publisher","first-page":"24666","DOI":"10.1074\/jbc.M111.236273","volume":"286","author":"K Yamanaka","year":"2011","unstructured":"Yamanaka, K., et al. 2011. 24(S)-hydroxycholesterol induces neuronal cell death through necroptosis, a form of programmed necrosis. Journal of Biological Chemistry 286 (28): 24666\u201324673.","journal-title":"Journal of Biological Chemistry"},{"issue":"6","key":"2323_CR16","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/82732","volume":"1","author":"N Holler","year":"2000","unstructured":"Holler, N., et al. 2000. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nature Immunology 1 (6): 489\u2013495.","journal-title":"Nature Immunology"},{"issue":"5","key":"2323_CR17","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1038\/s41423-020-00630-3","volume":"18","author":"D Bertheloot","year":"2021","unstructured":"Bertheloot, D., E. Latz, and B.S. Franklin. 2021. Necroptosis, pyroptosis and apoptosis: An intricate game of cell death. Cellular & Molecular Immunology 18 (5): 1106\u20131121.","journal-title":"Cellular & Molecular Immunology"},{"issue":"8","key":"2323_CR18","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.4049\/jimmunol.1701492","volume":"200","author":"M Brault","year":"2018","unstructured":"Brault, M., et al. 2018. Intracellular nucleic acid sensing triggers necroptosis through synergistic Type I IFN and TNF signaling. The Journal of Immunology 200 (8): 2748\u20132756.","journal-title":"The Journal of Immunology"},{"issue":"6","key":"2323_CR19","doi-asserted-by":"publisher","first-page":"536","DOI":"10.2174\/187152708787122941","volume":"7","author":"J Yan","year":"2008","unstructured":"Yan, J., and J.M. Greer. 2008. NF-kappa B, a potential therapeutic target for the treatment of multiple sclerosis. CNS & Neurological Disorders: Drug Targets 7 (6): 536\u2013557.","journal-title":"CNS & Neurological Disorders: Drug Targets"},{"issue":"3","key":"2323_CR20","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.molcel.2011.06.011","volume":"43","author":"M Feoktistova","year":"2011","unstructured":"Feoktistova, M., et al. 2011. cIAPs block ripoptosome formation, a RIP1\/caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoforms. Molecular Cell 43 (3): 449\u2013463.","journal-title":"Molecular Cell"},{"issue":"2","key":"2323_CR21","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.cell.2012.06.019","volume":"150","author":"J Li","year":"2012","unstructured":"Li, J., et al. 2012. The RIP1\/RIP3 necrosome forms a functional amyloid signaling complex required for programmed necrosis. Cell 150 (2): 339\u2013350.","journal-title":"Cell"},{"issue":"19","key":"2323_CR22","doi-asserted-by":"publisher","first-page":"9452","DOI":"10.7150\/thno.62376","volume":"11","author":"C Xu","year":"2021","unstructured":"Xu, C., et al. 2021. TNF-alpha-dependent neuronal necroptosis regulated in Alzheimer\u2019s disease by coordination of RIPK1-p62 complex with autophagic UVRAG. Theranostics 11 (19): 9452\u20139469.","journal-title":"Theranostics"},{"issue":"1","key":"2323_CR23","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s13024-023-00686-5","volume":"18","author":"L Geng","year":"2023","unstructured":"Geng, L., et al. 2023. MLKL deficiency alleviates neuroinflammation and motor deficits in the alpha-synuclein transgenic mouse model of Parkinson\u2019s disease. Molecular Neurodegeneration 18 (1): 94.","journal-title":"Molecular Neurodegeneration"},{"issue":"4","key":"2323_CR24","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s11064-014-1510-0","volume":"40","author":"X Su","year":"2015","unstructured":"Su, X., et al. 2015. Necrostatin-1 ameliorates intracerebral hemorrhage-induced brain injury in mice through inhibiting RIP1\/RIP3 pathway. Neurochemical Research 40 (4): 643\u2013650.","journal-title":"Neurochemical Research"},{"issue":"3","key":"2323_CR25","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.jhep.2013.03.033","volume":"59","author":"C Brenner","year":"2013","unstructured":"Brenner, C., et al. 2013. Decoding cell death signals in liver inflammation. Journal of Hepatology 59 (3): 583\u2013594.","journal-title":"Journal of Hepatology"},{"key":"2323_CR26","doi-asserted-by":"publisher","first-page":"916249","DOI":"10.3389\/fnmol.2022.916249","volume":"15","author":"X Zhang","year":"2022","unstructured":"Zhang, X., et al. 2022. Necrosulfonamide alleviates acute brain injury of intracerebral hemorrhage via inhibiting inflammation and necroptosis. Frontiers in Molecular Neuroscience 15: 916249.","journal-title":"Frontiers in Molecular Neuroscience"},{"key":"2323_CR27","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.3389\/fphar.2019.01538","volume":"10","author":"J Jiao","year":"2019","unstructured":"Jiao, J., et al. 2019. Necrosulfonamide ameliorates neurological impairment in spinal cord injury by improving antioxidative capacity. Frontiers in Pharmacology 10: 1538.","journal-title":"Frontiers in Pharmacology"},{"key":"2323_CR28","doi-asserted-by":"publisher","first-page":"115338","DOI":"10.1016\/j.bcp.2022.115338","volume":"206","author":"W Yang","year":"2022","unstructured":"Yang, W., et al. 2022. Necrosulfonamide ameliorates intestinal inflammation via inhibiting GSDMD-medicated pyroptosis and MLKL-mediated necroptosis. Biochemical Pharmacology 206: 115338.","journal-title":"Biochemical Pharmacology"},{"issue":"14","key":"2323_CR29","doi-asserted-by":"publisher","first-page":"8078","DOI":"10.1111\/jcmm.15439","volume":"24","author":"C Han","year":"2020","unstructured":"Han, C., et al. 2020. New mechanism of nerve injury in Alzheimer\u2019s disease: Beta-amyloid-induced neuronal pyroptosis. Journal of Cellular and Molecular Medicine 24 (14): 8078\u20138090.","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"5","key":"2323_CR30","first-page":"4113","volume":"18","author":"Y Wang","year":"2019","unstructured":"Wang, Y., et al. 2019. Necrostatin-1 ameliorates the pathogenesis of experimental autoimmune encephalomyelitis by suppressing apoptosis and necroptosis of oligodendrocyte precursor cells. Experimental and Therapeutic Medicine 18 (5): 4113\u20134119.","journal-title":"Experimental and Therapeutic Medicine"},{"issue":"1","key":"2323_CR31","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s40478-020-00938-1","volume":"8","author":"RE James","year":"2020","unstructured":"James, R.E., et al. 2020. Persistent elevation of intrathecal pro-inflammatory cytokines leads to multiple sclerosis-like cortical demyelination and neurodegeneration. Acta Neuropathologica Communications 8 (1): 66.","journal-title":"Acta Neuropathologica Communications"},{"issue":"2","key":"2323_CR32","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.cyto.2015.06.004","volume":"76","author":"S Dhib-Jalbut","year":"2015","unstructured":"Dhib-Jalbut, S., and D.V. Kalvakolanu. 2015. Microglia and necroptosis: The culprits of neuronal cell death in multiple sclerosis. Cytokine 76 (2): 583\u2013584.","journal-title":"Cytokine"},{"issue":"3","key":"2323_CR33","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1111\/imm.12776","volume":"152","author":"Z Xie","year":"2017","unstructured":"Xie, Z., et al. 2017. 1,25-dihydroxyvitamin D(3) -induced dendritic cells suppress experimental autoimmune encephalomyelitis by increasing proportions of the regulatory lymphocytes and reducing T helper type 1 and type 17 cells. Immunology 152 (3): 414\u2013424.","journal-title":"Immunology"},{"key":"2323_CR34","doi-asserted-by":"publisher","first-page":"593368","DOI":"10.3389\/fimmu.2020.593368","volume":"11","author":"Y Yu","year":"2020","unstructured":"Yu, Y., et al. 2020. Bixin attenuates experimental autoimmune encephalomyelitis by suppressing TXNIP\/NLRP3 inflammasome activity and activating NRF2 signaling. Frontiers in Immunology 11: 593368.","journal-title":"Frontiers in Immunology"},{"issue":"1","key":"2323_CR35","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12964-022-00862-y","volume":"20","author":"L Cai","year":"2022","unstructured":"Cai, L., et al. 2022. ACT001 attenuates microglia-mediated neuroinflammation after traumatic brain injury via inhibiting AKT\/NFkappaB\/NLRP3 pathway. Cell Communication and Signaling: CCS 20 (1): 56.","journal-title":"Cell Communication and Signaling: CCS"},{"key":"2323_CR36","doi-asserted-by":"publisher","first-page":"4","DOI":"10.12688\/f1000research.7046.1","volume":"4","author":"JM Murphy","year":"2015","unstructured":"Murphy, J.M., and J.E. Vince. 2015. Post-translational control of RIPK3 and MLKL mediated necroptotic cell death. F1000Res 4: 4.","journal-title":"F1000Res"},{"key":"2323_CR37","doi-asserted-by":"publisher","first-page":"106697","DOI":"10.1016\/j.phrs.2023.106697","volume":"189","author":"FL Shi","year":"2023","unstructured":"Shi, F.L., et al. 2023. Dimethyl fumarate inhibits necroptosis and alleviates systemic inflammatory response syndrome by blocking the RIPK1-RIPK3-MLKL axis. Pharmacological Research 189: 106697.","journal-title":"Pharmacological Research"},{"issue":"5","key":"2323_CR38","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1002\/glia.23954","volume":"69","author":"M Borggrewe","year":"2021","unstructured":"Borggrewe, M., et al. 2021. Regionally diverse astrocyte subtypes and their heterogeneous response to EAE. Glia 69 (5): 1140\u20131154.","journal-title":"Glia"},{"key":"2323_CR39","doi-asserted-by":"publisher","first-page":"108995","DOI":"10.1016\/j.fsi.2023.108995","volume":"140","author":"Y Lei","year":"2023","unstructured":"Lei, Y., et al. 2023. Evodiamine alleviates DEHP-induced hepatocyte pyroptosis, necroptosis and immunosuppression in grass carp through ROS-regulated TLR4 \/ MyD88 \/ NF-kappaB pathway. Fish & Shellfish Immunology 140: 108995.","journal-title":"Fish & Shellfish Immunology"},{"issue":"1","key":"2323_CR40","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12876-022-02208-x","volume":"22","author":"C Duan","year":"2022","unstructured":"Duan, C., et al. 2022. RIP3 knockdown inhibits necroptosis of human intestinal epithelial cells via TLR4\/MyD88\/NF-kappaB signaling and ameliorates murine colitis. BMC Gastroenterology 22 (1): 137.","journal-title":"BMC Gastroenterology"},{"key":"2323_CR41","doi-asserted-by":"publisher","first-page":"113319","DOI":"10.1016\/j.ecoenv.2022.113319","volume":"233","author":"S Li","year":"2022","unstructured":"Li, S., et al. 2022. Protective role of curcumin on aflatoxin B1-induced TLR4\/RIPK pathway mediated-necroptosis and inflammation in chicken liver. Ecotoxicology and Environmental Safety 233: 113319.","journal-title":"Ecotoxicology and Environmental Safety"},{"key":"2323_CR42","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3389\/fnmol.2016.00084","volume":"9","author":"SM Leibowitz","year":"2016","unstructured":"Leibowitz, S.M., and J. Yan. 2016. NF-kappaB pathways in the pathogenesis of multiple sclerosis and the therapeutic implications. Frontiers in Molecular Neuroscience 9: 84.","journal-title":"Frontiers in Molecular Neuroscience"},{"issue":"1","key":"2323_CR43","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12974-023-02721-0","volume":"20","author":"Y Wang","year":"2023","unstructured":"Wang, Y., et al. 2023. Regulatory T cells alleviate myelin loss and cognitive dysfunction by regulating neuroinflammation and microglial pyroptosis via TLR4\/MyD88\/NF-kappaB pathway in LPC-induced demyelination. Journal of Neuroinflammation 20 (1): 41.","journal-title":"Journal of Neuroinflammation"},{"issue":"11","key":"2323_CR44","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.molmed.2007.09.002","volume":"13","author":"T Kawai","year":"2007","unstructured":"Kawai, T., and S. Akira. 2007. Signaling to NF-kappaB by Toll-like receptors. Trends in Molecular Medicine 13 (11): 460\u2013469.","journal-title":"Trends in Molecular Medicine"},{"issue":"3","key":"2323_CR45","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.cell.2022.12.048","volume":"186","author":"ID Iliev","year":"2023","unstructured":"Iliev, I.D., W.Y. Lin, and S.L. Gaffen. 2023. When IL-17 gets on your nerves. Cell 186 (3): 466\u2013468.","journal-title":"Cell"},{"issue":"4","key":"2323_CR46","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1111\/cns.14060","volume":"29","author":"D Zhang","year":"2023","unstructured":"Zhang, D., et al. 2023. Ferulic acid alleviates sciatica by inhibiting neuroinflammation and promoting nerve repair via the TLR4\/NF-kappaB pathway. CNS Neuroscience & Therapeutics 29 (4): 1000\u20131011.","journal-title":"CNS Neuroscience & Therapeutics"},{"issue":"5","key":"2323_CR47","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/s41590-019-0377-2","volume":"20","author":"RA Drummond","year":"2019","unstructured":"Drummond, R.A., et al. 2019. CARD9(+) microglia promote antifungal immunity via IL-1beta- and CXCL1-mediated neutrophil recruitment. Nature Immunology 20 (5): 559\u2013570.","journal-title":"Nature Immunology"},{"issue":"1","key":"2323_CR48","doi-asserted-by":"publisher","first-page":"2041790","DOI":"10.1080\/20002297.2022.2041790","volume":"14","author":"F Geng","year":"2022","unstructured":"Geng, F., et al. 2022. Porphyromonas gingivalis lipopolysaccharide induced RIPK3\/MLKL-mediated necroptosis of oral epithelial cells and the further regulation in macrophage activation. Journal of Oral Microbiology 14 (1): 2041790.","journal-title":"Journal of Oral Microbiology"},{"issue":"2","key":"2323_CR49","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/ced.12252","volume":"39","author":"SM Lwin","year":"2014","unstructured":"Lwin, S.M., I. Kimber, and J.P. McFadden. 2014. Acne, quorum sensing and danger. Clinical and Experimental Dermatology 39 (2): 162\u2013167.","journal-title":"Clinical and Experimental Dermatology"},{"issue":"8","key":"2323_CR50","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/nrd.2018.97","volume":"17","author":"M Mangan","year":"2018","unstructured":"Mangan, M., et al. 2018. Targeting the NLRP3 inflammasome in inflammatory diseases. Nature Reviews. Drug Discovery 17 (8): 588\u2013606.","journal-title":"Nature Reviews. Drug Discovery"},{"key":"2323_CR51","doi-asserted-by":"publisher","first-page":"879021","DOI":"10.3389\/fnagi.2022.879021","volume":"14","author":"HM Blevins","year":"2022","unstructured":"Blevins, H.M., et al. 2022. The NLRP3 inflammasome pathway: a review of mechanisms and inhibitors for the treatment of inflammatory diseases. Front Aging Neurosci 14: 879021.","journal-title":"Front Aging Neurosci"},{"key":"2323_CR52","doi-asserted-by":"crossref","unstructured":"Li, S., et al. 2021. NLRP3\/caspase-1\/GSDMD-mediated pyroptosis exerts a crucial role in astrocyte pathological injury in mouse model of depression. JCI Insight 6 (23): e146852.","DOI":"10.1172\/jci.insight.146852"},{"issue":"2","key":"2323_CR53","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1056\/NEJMra1401483","volume":"378","author":"DS Reich","year":"2018","unstructured":"Reich, D.S., C.F. Lucchinetti, and P.A. Calabresi. 2018. Multiple sclerosis. New England Journal of Medicine 378 (2): 169\u2013180.","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"2323_CR54","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/S1474-4422(22)00289-7","volume":"22","author":"T Kuhlmann","year":"2023","unstructured":"Kuhlmann, T., et al. 2023. Multiple sclerosis progression: Time for a new mechanism-driven framework. Lancet Neurology 22 (1): 78\u201388.","journal-title":"Lancet Neurology"},{"key":"2323_CR55","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/978-3-031-55529-9_25","volume":"37","author":"BP Hammond","year":"2024","unstructured":"Hammond, B.P., et al. 2024. Microglia and multiple sclerosis. Adv Neurobiol 37: 445\u2013456.","journal-title":"Adv Neurobiol"},{"key":"2323_CR56","doi-asserted-by":"crossref","unstructured":"Azzolini, F., et al. 2022. Neuroinflammation is associated with GFAP and sTREM2 levels in multiple sclerosis. Biomolecules 12 (2): 222.","DOI":"10.3390\/biom12020222"},{"issue":"5","key":"2323_CR57","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/s41582-023-00801-6","volume":"19","author":"L Klotz","year":"2023","unstructured":"Klotz, L., J. Antel, and T. Kuhlmann. 2023. Inflammation in multiple sclerosis: Consequences for remyelination and disease progression. Nature Reviews. Neurology 19 (5): 305\u2013320.","journal-title":"Nature Reviews. Neurology"},{"key":"2323_CR58","doi-asserted-by":"crossref","unstructured":"Lopez-Muguruza, E. and C. Matute. 2023. Alterations of oligodendrocyte and myelin energy metabolism in multiple sclerosis. International Journal of Molecular Sciences 24 (16): 12912.","DOI":"10.3390\/ijms241612912"},{"key":"2323_CR59","doi-asserted-by":"publisher","first-page":"102588","DOI":"10.1016\/j.conb.2022.102588","volume":"75","author":"T Brummer","year":"2022","unstructured":"Brummer, T., F. Zipp, and S. Bittner. 2022. T cell-neuron interaction in inflammatory and progressive multiple sclerosis biology. Current Opinion in Neurobiology 75: 102588.","journal-title":"Current Opinion in Neurobiology"},{"issue":"3","key":"2323_CR60","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.molcel.2018.09.011","volume":"72","author":"Z Ying","year":"2018","unstructured":"Ying, Z., et al. 2018. Mixed lineage kinase domain-like protein mlkl breaks down myelin following nerve injury. Molecular Cell 72 (3): 457-468.e5.","journal-title":"Molecular Cell"},{"key":"2323_CR61","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.bbrc.2023.04.023","volume":"661","author":"X Xu","year":"2023","unstructured":"Xu, X., et al. 2023. Luteolin ameliorates necroptosis in Glucocorticoid-induced osteonecrosis of the femoral head via RIPK1\/RIPK3\/MLKL pathway based on network pharmacology analysis. Biochemical and Biophysical Research Communications 661: 108\u2013118.","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"2","key":"2323_CR62","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/s41419-020-2328-0","volume":"11","author":"X Duan","year":"2020","unstructured":"Duan, X., et al. 2020. Inhibition of keratinocyte necroptosis mediated by RIPK1\/RIPK3\/MLKL provides a protective effect against psoriatic inflammation. Cell Death & Disease 11 (2): 134.","journal-title":"Cell Death & Disease"},{"issue":"9","key":"2323_CR63","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1007\/s00210-019-01656-9","volume":"392","author":"YY Zhang","year":"2019","unstructured":"Zhang, Y.Y., et al. 2019. Ligustroflavone reduces necroptosis in rat brain after ischemic stroke through targeting RIPK1\/RIPK3\/MLKL pathway. Naunyn-Schmiedeberg\u2019s Archives of Pharmacology 392 (9): 1085\u20131095.","journal-title":"Naunyn-Schmiedeberg's Archives of Pharmacology"},{"issue":"3","key":"2323_CR64","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/s41419-023-05660-z","volume":"14","author":"Z Huang","year":"2023","unstructured":"Huang, Z., et al. 2023. RIP3-mediated microglial necroptosis promotes neuroinflammation and neurodegeneration in the early stages of diabetic retinopathy. Cell Death & Disease 14 (3): 227.","journal-title":"Cell Death & Disease"},{"issue":"1","key":"2323_CR65","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00401-009-0601-5","volume":"119","author":"M Bradl","year":"2010","unstructured":"Bradl, M., and H. Lassmann. 2010. Oligodendrocytes: Biology and pathology. Acta Neuropathologica 119 (1): 37\u201353.","journal-title":"Acta Neuropathologica"},{"issue":"12","key":"2323_CR66","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/nrn.2017.136","volume":"18","author":"R Franklin","year":"2017","unstructured":"Franklin, R., and C. Ffrench-Constant. 2017. Regenerating CNS myelin - from mechanisms to experimental medicines. Nature Reviews Neuroscience 18 (12): 753\u2013769.","journal-title":"Nature Reviews Neuroscience"},{"issue":"7321","key":"2323_CR67","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/nature09614","volume":"468","author":"KA Nave","year":"2010","unstructured":"Nave, K.A. 2010. Myelination and support of axonal integrity by glia. Nature 468 (7321): 244\u2013252.","journal-title":"Nature"},{"issue":"Pt 1","key":"2323_CR68","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1093\/brain\/awu375","volume":"138","author":"A Wegener","year":"2015","unstructured":"Wegener, A., et al. 2015. Gain of Olig2 function in oligodendrocyte progenitors promotes remyelination. Brain 138 (Pt 1): 120\u2013135.","journal-title":"Brain"},{"issue":"6","key":"2323_CR69","doi-asserted-by":"publisher","first-page":"3258","DOI":"10.1007\/s12035-023-03650-y","volume":"61","author":"H Zhao","year":"2024","unstructured":"Zhao, H., et al. 2024. Electroacupuncture inhibits neuroinflammation induced by astrocytic necroptosis through RIP1\/MLKL\/TLR4 pathway in a mouse model of spinal cord injury. Molecular Neurobiology 61 (6): 3258\u20133271.","journal-title":"Molecular Neurobiology"},{"issue":"8","key":"2323_CR70","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/s41582-019-0184-2","volume":"15","author":"AF Lloyd","year":"2019","unstructured":"Lloyd, A.F., and V.E. Miron. 2019. The pro-remyelination properties of microglia in the central nervous system. Nature Reviews. Neurology 15 (8): 447\u2013458.","journal-title":"Nature Reviews. Neurology"},{"issue":"17","key":"2323_CR71","doi-asserted-by":"publisher","first-page":"8480","DOI":"10.7150\/thno.60031","volume":"11","author":"Q Wu","year":"2021","unstructured":"Wu, Q., et al. 2021. Astrocytic YAP protects the optic nerve and retina in an experimental autoimmune encephalomyelitis model through TGF-beta signaling. Theranostics 11 (17): 8480\u20138499.","journal-title":"Theranostics"},{"issue":"3","key":"2323_CR72","doi-asserted-by":"publisher","first-page":"152388","DOI":"10.1016\/j.imbio.2023.152388","volume":"228","author":"N Xu","year":"2023","unstructured":"Xu, N., et al. 2023. Taurochenodeoxycholic acid reduces astrocytic neuroinflammation and alleviates experimental autoimmune encephalomyelitis in mice. Immunobiology 228 (3): 152388.","journal-title":"Immunobiology"},{"issue":"1","key":"2323_CR73","doi-asserted-by":"publisher","first-page":"10877","DOI":"10.1038\/s41598-024-61508-2","volume":"14","author":"EO Takase","year":"2024","unstructured":"Takase, E.O., et al. 2024. Astroglial connexin 43 is a novel therapeutic target for chronic multiple sclerosis model. Science and Reports 14 (1): 10877.","journal-title":"Science and Reports"},{"issue":"1","key":"2323_CR74","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12964-023-01387-8","volume":"22","author":"X Wei","year":"2024","unstructured":"Wei, X., et al. 2024. Free heme induces neuroinflammation and cognitive impairment by microglial activation via the TLR4\/MyD88\/NF-kappaB signaling pathway. Cell Communication and Signaling: CCS 22 (1): 16.","journal-title":"Cell Communication and Signaling: CCS"},{"issue":"5","key":"2323_CR75","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.4049\/jimmunol.1601757","volume":"198","author":"KD Gutierrez","year":"2017","unstructured":"Gutierrez, K.D., et al. 2017. MLKL activation triggers NLRP3-mediated processing and release of IL-1beta independently of Gasdermin-D. The Journal of Immunology 198 (5): 2156\u20132164.","journal-title":"The Journal of Immunology"},{"key":"2323_CR76","doi-asserted-by":"publisher","first-page":"6282","DOI":"10.1038\/ncomms7282","volume":"6","author":"KE Lawlor","year":"2015","unstructured":"Lawlor, K.E., et al. 2015. RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL. Nature Communications 6: 6282.","journal-title":"Nature Communications"},{"issue":"2","key":"2323_CR77","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1007\/s12035-023-03628-w","volume":"61","author":"X Lu","year":"2024","unstructured":"Lu, X., et al. 2024. Hypoxic preconditioning attenuates neuroinflammation via inhibiting NF-kappaB\/NLRP3 axis mediated by p-MLKL after transient global cerebral ischemia. Molecular Neurobiology 61 (2): 1080\u20131099.","journal-title":"Molecular Neurobiology"},{"issue":"2","key":"2323_CR78","doi-asserted-by":"publisher","first-page":"112648","DOI":"10.1016\/j.yexcr.2021.112648","volume":"405","author":"J Zhang","year":"2021","unstructured":"Zhang, J., and K. Wei. 2021. Necrosulfonamide reverses pyroptosis-induced inhibition of proliferation and differentiation of osteoblasts through the NLRP3\/caspase-1\/GSDMD pathway. Experimental Cell Research 405 (2): 112648.","journal-title":"Experimental Cell Research"},{"key":"2323_CR79","doi-asserted-by":"publisher","first-page":"117673","DOI":"10.1016\/j.biopha.2024.117673","volume":"181","author":"J Yang","year":"2024","unstructured":"Yang, J., et al. 2024. Cellucalst enzyme-assisted extraction of Sargassum horneri enhances the immunomodulation by regulating TLR4\/MyD88\/NF-kB pathway in murine splenocytes with or without Concanavalin A. Biomedicine & Pharmacotherapy 181: 117673.","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"2323_CR80","doi-asserted-by":"publisher","first-page":"108939","DOI":"10.1016\/j.clim.2022.108939","volume":"236","author":"Y Liu","year":"2022","unstructured":"Liu, Y., et al. 2022. Galectin-3 regulates microglial activation and promotes inflammation through TLR4\/MyD88\/NF-kB in experimental autoimmune uveitis. Clinical Immunology 236: 108939.","journal-title":"Clinical Immunology"},{"key":"2323_CR81","doi-asserted-by":"publisher","first-page":"155065","DOI":"10.1016\/j.phymed.2023.155065","volume":"122","author":"J Oh","year":"2024","unstructured":"Oh, J., et al. 2024. Ginsenoside-Re inhibits experimental autoimmune encephalomyelitis as a mouse model of multiple sclerosis by downregulating TLR4\/MyD88\/NF-kappaB signaling pathways. Phytomedicine 122: 155065.","journal-title":"Phytomedicine"},{"key":"2323_CR82","doi-asserted-by":"publisher","first-page":"577284","DOI":"10.1016\/j.jneuroim.2020.577284","volume":"346","author":"MF Guo","year":"2020","unstructured":"Guo, M.F., et al. 2020. Fasudil inhibits the activation of microglia and astrocytes of transgenic Alzheimer\u2019s disease mice via the downregulation of TLR4\/Myd88\/NF-kappaB pathway. Journal of Neuroimmunology 346: 577284.","journal-title":"Journal of Neuroimmunology"},{"issue":"5","key":"2323_CR83","first-page":"2683","volume":"24","author":"QX Zhang","year":"2020","unstructured":"Zhang, Q.X., et al. 2020. Necrosulfonamide (NSA) protects intervertebral disc degeneration via necroptosis and apoptosis inhibition. European Review for Medical and Pharmacological Sciences 24 (5): 2683\u20132691.","journal-title":"European Review for Medical and Pharmacological Sciences"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-025-02323-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-025-02323-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-025-02323-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T14:02:50Z","timestamp":1766412170000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10753-025-02323-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":83,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2323"],"URL":"https:\/\/doi.org\/10.1007\/s10753-025-02323-3","relation":{},"ISSN":["1573-2576"],"issn-type":[{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]},"assertion":[{"value":"7 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}]}}